Cases & Deals

  • Home
  • Practices
  • Faron Pharmaceuticals places €3.1 million of Ordinary Shares on AIM

Share

Faron Pharmaceuticals places €3.1 million of Ordinary Shares on AIM

March 2019

Client(s) Faron Pharmaceuticals Oy

Jones Day represented Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection its €3.1 million (US$3.5 million) placement of Ordinary Shares on the Alternative Investment Market (AIM).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.